Stock Comparison
ABT vs EW
Abbott Laboratories and Edwards Lifesciences Corp side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$192.35B
$51.99B
P/E (TTM)
35.7
53.7
Forward P/E
20.0
30.1
Price/Sales
4.1
8.0
Price/Book
3.7
4.9
EV/EBITDA
18.6
29.3
Dividend Yield
1.66%
—
Profitability
Net Margin
13.91%
17.34%
Operating Margin
18.17%
27.62%
Return on Equity
10.60%
9.18%
Return on Assets
5.33%
8.37%
Growth (YoY)
Revenue Growth
13.00%
13.60%
Earnings Growth
-47.50%
-25.40%
Price & Risk
Beta
0.6
0.8
52-Week High
$134.48
$95.17
52-Week Low
$82.56
$72.65
Analyst Target
$118.42
$100.96
Compare ABT and EW your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.